Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenoviridae Infections”

276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 276 results

Early research (Phase 1)Study completedNCT00384787
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT04297917
What this trial is testing

First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection

Who this might be right for
Hepatitis BHealthy
Barinthus Biotherapeutics 47
Early research (Phase 1)Study completedNCT01701336
What this trial is testing

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients

Who this might be right for
Hepatitis C
ReiThera Srl 9
Testing effectiveness (Phase 2)Study completedNCT04341389
What this trial is testing

A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)

Who this might be right for
COVID-19
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 508
Early research (Phase 1)Study completedNCT01979406
What this trial is testing

Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Who this might be right for
Anthrax Infection
Emergent BioSolutions 120
Not applicableStudy completedNCT04893837
What this trial is testing

Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)

Who this might be right for
Brain Injuries, Traumatic
University of Alabama at Birmingham 399
Early research (Phase 1)Study completedNCT00270465
What this trial is testing

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableStudy completedNCT04056546
What this trial is testing

Interest of Rapid Typing in Adenovirus Infections.

Who this might be right for
AdenovirusAdenovirus DiseaseGenotyping
University Hospital, Bordeaux 296
Early research (Phase 1)Study completedNCT00849680
What this trial is testing

Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

Who this might be right for
HIV-1HIV Infections
Merck Sharp & Dohme LLC 317
Not applicableEnded earlyNCT02420080
What this trial is testing

Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304

Who this might be right for
Adenovirus
Jazz Pharmaceuticals 100
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Early research (Phase 1)Study completedNCT00755703
What this trial is testing

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Who this might be right for
Influenza A Subtype H5N1 Infection
Altimmune, Inc. 48
Early research (Phase 1)Looking for participantsNCT07416539
What this trial is testing

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

Who this might be right for
COVID - 19SARS CoV-2
Rokote Laboratories Finland Oy 20
Early research (Phase 1)Study completedNCT01018459
What this trial is testing

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT02289027
What this trial is testing

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Who this might be right for
Ebola Vaccines
Centre Hospitalier Universitaire Vaudois 120
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Not applicableUnknownNCT06224062
What this trial is testing

Virus and Bronchial Epithelium in Children and the Elderly

Who this might be right for
SARS-CoV-2
University Hospital, Bordeaux 200
Large-scale testing (Phase 3)Study completedNCT00382408
What this trial is testing

A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001

Who this might be right for
Respiratory Tract Diseases
Duramed Research 4,040
Early research (Phase 1)Study completedNCT04854746
What this trial is testing

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine

Who this might be right for
Norovirus Infections
Vaxart 66
Load More Results